Experts at The Institute of Cancer Research, London, have hailed findings from a major international trial showing that a personalised cancer vaccine can significantly reduce the risk of melanoma ...

Scientists have identified the genetic blueprints of 18 previously unknown bacterial species in DNA samples from people with prostate cancer. The study, led by researchers at the University of East ...

Nearly one third (29.2 per cent) of patients with advanced melanoma saw their tumours disappear completely on scans after receiving lifileucel TIL therapy alongside an immune checkpoint inhibitor, ...

The Audit & Risk Committee supervises internal and external audit processes in order to safeguard the integrity of the ICR's financial systems and ensure economy, efficiency and effectiveness in the ...

Our researchers play key roles in international research efforts that are transforming how these devastating diseases are treated, as well as pioneering studies of cancer types not studied elsewhere ...

Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research ...

These days, in the era of personalised medicine, whenever researchers discover a new cancer drug they are expected to show exactly how it works and to prove that it is exerting its therapeutic effect ...

The latest major breakthrough in cancer is a drug called capivasertib, which has shown ‘remarkable’ results against advanced breast cancer in its first phase III trial. Results released at the ...

A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and/or metastatic head and neck cancer whose disease has ...

Darwinian evolution has influenced and inspired the rapidly growing field of evolutionary medicine that uses evolution to approach the diagnosis, treatment, and prevention of human diseases. Cancer ...

As we enter 2026, scientists at The Institute of Cancer Research, London, share the developments expected this year that could soon change how cancer is treated – from technologies designed to deliver ...

The Institute of Cancer Research, London, is the joint recipient of a major new Medical Research Council (MRC) grant to advance how sensitive medical imaging data can be used for research. This award ...